Metastatic Melanoma: A New Era of Treatments

News

Historically, the prognosis for metastatic melanoma has been poor. Patients with metastatic disease have a median survival of 6-9 months and less than 10% survive 5 years.1, 2 Treatments for
metastatic melanoma since the 1970’s included chemotherapy. There had been no new therapies for over twenty years. In the 1990’s, the use of immunotherapies introduced a new era of treatments.

View PDF